Fuad Fares

2.8k total citations
83 papers, 2.2k citations indexed

About

Fuad Fares is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Fuad Fares has authored 83 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 15 papers in Genetics. Recurrent topics in Fuad Fares's work include Neuroscience and Neuropharmacology Research (15 papers), Hypothalamic control of reproductive hormones (8 papers) and Genomics, phytochemicals, and oxidative stress (7 papers). Fuad Fares is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Hypothalamic control of reproductive hormones (8 papers) and Genomics, phytochemicals, and oxidative stress (7 papers). Fuad Fares collaborates with scholars based in Israel, United States and Norway. Fuad Fares's co-authors include S. Yannai, Moshe Gavish, Xiaokang Ge, Irving Boime, Philip S. LaPolt, K Nishimori, Aaron J.W. Hsueh, Abraham Haim, Alicia J. El Haj and Nachman Gruener and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Fuad Fares

81 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuad Fares Israel 25 984 352 322 320 313 83 2.2k
Silvana A. Andrić Serbia 30 548 0.6× 258 0.7× 373 1.2× 165 0.5× 376 1.2× 86 2.1k
John E. Bleasdale United States 25 1.8k 1.9× 126 0.4× 187 0.6× 612 1.9× 181 0.6× 56 3.7k
Canan G. Nebigil France 31 1.7k 1.7× 172 0.5× 90 0.3× 623 1.9× 185 0.6× 67 3.2k
Luz Candenas Spain 30 1.2k 1.2× 241 0.7× 264 0.8× 1.1k 3.3× 948 3.0× 96 3.1k
D. Philibert France 30 885 0.9× 237 0.7× 1.4k 4.4× 177 0.6× 463 1.5× 75 2.9k
Yoshio Osawa United States 34 1.2k 1.2× 227 0.6× 1.8k 5.7× 217 0.7× 959 3.1× 109 3.5k
Trevor W. Sweatman United States 31 770 0.8× 119 0.3× 400 1.2× 231 0.7× 66 0.2× 71 3.2k
Francesco Michelangeli United Kingdom 37 1.9k 1.9× 94 0.3× 160 0.5× 477 1.5× 399 1.3× 92 3.5k
Junko Wakabayashi Japan 14 2.5k 2.5× 112 0.3× 190 0.6× 300 0.9× 193 0.6× 18 3.3k
Michael W. Kilgore United States 27 1.3k 1.3× 134 0.4× 1.7k 5.4× 111 0.3× 542 1.7× 43 3.3k

Countries citing papers authored by Fuad Fares

Since Specialization
Citations

This map shows the geographic impact of Fuad Fares's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuad Fares with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuad Fares more than expected).

Fields of papers citing papers by Fuad Fares

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuad Fares. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuad Fares. The network helps show where Fuad Fares may publish in the future.

Co-authorship network of co-authors of Fuad Fares

This figure shows the co-authorship network connecting the top 25 collaborators of Fuad Fares. A scholar is included among the top collaborators of Fuad Fares based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuad Fares. Fuad Fares is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fares, Fuad, et al.. (2025). Molecular and Functional Insights into Thyrostimulin and Its Subunits-GPA2/GPB5. International Journal of Molecular Sciences. 26(23). 11523–11523.
3.
Bergman, Margalit, et al.. (2019). Inula Viscosa Extract Inhibits Growth of Colorectal Cancer Cells in vitro and in vivo Through Induction of Apoptosis. Frontiers in Oncology. 9. 227–227. 49 indexed citations
5.
Wasser, Solomon P., et al.. (2015). The Shaggy Ink Cap Medicinal Mushroom, Coprinus comatus (Higher Basidiomycetes) Extract Induces Apoptosis in Ovarian Cancer Cells via Extrinsic and Intrinsic Apoptotic Pathways. International journal of medicinal mushrooms. 17(12). 1127–1136. 8 indexed citations
6.
Zafrir, Barak, et al.. (2015). Endothelial nitric oxide synthase polymorphism and prognosis in systolic heart failure patients. Nitric Oxide. 47. 91–96. 6 indexed citations
7.
Fares, Fuad, et al.. (2013). Patents on Enhancing the Potency and Longevity of Highly Valuable Protein Hormones. Recent Patents on Endocrine Metabolic & Immune Drug Discovery. 7(2). 148–154. 3 indexed citations
8.
Fares, Fuad, et al.. (2012). Reproductive and metabolic responses of desert adapted common spiny male mice (Acomys cahirinus) to vasopressin treatment. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 162(4). 349–356. 6 indexed citations
9.
Haim, Abraham, et al.. (2010). Effects of chronobiology on prostate cancer cells growth in vivo. Sleep Science. 3(1). 32–35. 11 indexed citations
10.
Fares, Fuad, et al.. (2010). The potential efficacy of 3,3′-diindolylmethane in prevention of prostate cancer development. European Journal of Cancer Prevention. 19(3). 199–203. 22 indexed citations
11.
Feiner, Benjamin, et al.. (2009). Does COLIA1 SP1-binding site polymorphism predispose women to pelvic organ prolapse?. International Urogynecology Journal. 20(9). 1061–1065. 23 indexed citations
12.
Fares, Fuad, et al.. (2008). A differential response in the reproductive system and energy balance of spiny mice Acomys populations to vasopressin treatment. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 151(4). 499–504. 12 indexed citations
14.
Fares, Fuad. (2006). The role of O-linked and N-linked oligosaccharides on the structure–function of glycoprotein hormones: Development of agonists and antagonists. Biochimica et Biophysica Acta (BBA) - General Subjects. 1760(4). 560–567. 78 indexed citations
15.
Fares, Fuad, Miriam David, Aaron Lerner, et al.. (2006). Paternal isodisomy of chromosome 7 with cystic fibrosis and overgrowth. American Journal of Medical Genetics Part A. 140A(16). 1785–1788. 17 indexed citations
16.
Fares, Fuad, et al.. (1999). Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochemical Pharmacology. 58(2). 273–278. 80 indexed citations
17.
Ge, Xiaokang, S. Yannai, Gad Rennert, Nachman Gruener, & Fuad Fares. (1996). 3,3′-Diindolylmethane Induces Apoptosis in Human Cancer Cells. Biochemical and Biophysical Research Communications. 228(1). 153–158. 145 indexed citations
18.
Pixley, Mary R., et al.. (1996). Characterization of the O-Glycosylation Sites in the Chorionic Gonadotropin β Subunit in Vivo Using Site-directed Mutagenesis and Gene Transfer. Journal of Biological Chemistry. 271(34). 20797–20804. 27 indexed citations
19.
Barnea, Eytan R., Fuad Fares, & Moshe Gavish. (1989). Modulatory action of benzodiazepines on human term placental steroidogenesis in vitro. Molecular and Cellular Endocrinology. 64(2). 155–159. 47 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026